Package Leaflet: Information for the User
Xoterna Breezhaler 85 micrograms/43 micrograms inhalation powder (hard capsule)
indacaterol/glycopyrronium
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Instructions for using the Xoterna Breezhaler inhaler
What Xoterna Breezhaler is
This medicine contains two active substances called indacaterol and glycopyrronium, which belong to a class of medicines called bronchodilators.
What Xoterna Breezhaler is used for
This medicine is used to make breathing easier for adult patients who have difficulty breathing due to a lung disease called chronic obstructive pulmonary disease (COPD). In COPD, the muscles around the airways contract, making it difficult to breathe. This medicine blocks the contraction of these muscles in the lungs, making it easier for air to enter and leave the lungs.
If you use this medicine once a day, it will help reduce the effects of COPD on your daily life.
Do not use Xoterna Breezhaler
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before using Xoterna Breezhaler if any of the following apply to you:
If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist, or nurse before using this medicine.
While using Xoterna Breezhaler
Xoterna Breezhaler is used as ongoing treatment for your COPD. Do not use this medicine to treat sudden attacks of shortness of breath or wheezing.
Children and adolescents
Do not give this medicine to children or adolescents under 18 years of age. This is because its use has not been studied in this age group.
Other medicines and Xoterna Breezhaler
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Especially, tell your doctor or pharmacist if you are using:
Pregnancy and breastfeeding
There is no data on the use of this medicine in pregnant women, and it is not known whether the active substance of this medicine passes into breast milk. Indacaterol, one of the active substances of Xoterna Breezhaler, may inhibit labor due to its effect on the uterus.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. You should not use Xoterna Breezhaler unless your doctor tells you to.
Driving and using machines
This medicine is unlikely to affect your ability to drive or use machines. However, this medicine may cause dizziness (see section 4). If you feel dizzy while taking this medicine, do not drive or use machines.
Xoterna Breezhaler contains lactose
This medicine contains lactose (23.5 mg per capsule). If your doctor has told you that you have an intolerance to some sugars, talk to your doctor before taking this medicine.
Ask your doctor or pharmacist for advice before taking any medicine.
Follow the instructions for administration of this medicine exactly as told by your doctor or pharmacist. If you are not sure, ask your doctor or pharmacist again.
How much Xoterna Breezhaler to use
The usual dose is to inhale the contents of one capsule each day.
You only need to inhale the medicine once a day, as the effect of this medicine lasts for 24 hours. Do not use more than the dose prescribed by your doctor.
Elderly patients (75 years of age and older)
If you are 75 years of age or older, you can use this medicine at the same dose as other adults.
When to inhale Xoterna Breezhaler
Use this medicine at the same time each day. This will help you remember to use it.
You can inhale Xoterna Breezhaler at any time before or after food or drink.
How to inhale Xoterna Breezhaler
If you use more Xoterna Breezhaler than you should
If you have inhaled too much of this medicine or if someone uses your capsules accidentally, tell your doctor immediately or go to the nearest emergency room. Show the pack of Xoterna Breezhaler. Medical attention may be needed. You may notice that your heart beats faster than normal, or you may have a headache, feel drowsy, feel sick, or have to vomit, or you may notice changes in vision, constipation, or difficulty urinating.
If you forget to use Xoterna Breezhaler
If you forget to inhale a dose at the usual time, inhale it as soon as you can on that day. Then, the next day, inhale the next dose at the usual time. Do not inhale more than one dose on the same day.
How long to continue using Xoterna Breezhaler
Ask your doctor or pharmacist if you have any questions about how long to use this medicine.
If you have any other questions about using this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects may be serious:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
If you experience any of these serious side effects, seek medical help immediately.
Other side effects may include:
Very common (may affect more than 1 in 10 people)
Common
Uncommon
Rare (may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date refers to the last day of the month stated.
Do not store above 25°C.
Keep the capsules in the original blister to protect them from moisture and do not remove them until you are about to use them.
The inhaler from each pack should be discarded once you have used all the capsules.
Do not use this medicine if you notice the pack is damaged or shows signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Xoterna Breezhaler Composition
Appearance of Xoterna Breezhaler and Container Contents
The hard capsules of Xoterna Breezhaler 85 micrograms/43 micrograms powder for inhalation are transparent and yellow and contain a white or almost white powder. They have the product code "IGP110.50" printed in blue under two blue bars on the body and the company logo () printed in black on the cap.
In this package, you will find a device known as an inhaler, along with capsules in blisters. Each blister contains 6 or 10 hard capsules.
The following package sizes are available:
Single pack containing 6x1, 10x1, 12x1, 30x1, or 90x1 hard capsules, along with 1 inhaler.
Multipack containing 96 (4 packs of 24x1) hard capsules and 4 inhalers.
Multipack containing 150 (15 packs of 10x1) hard capsules and 15 inhalers.
Multipack containing 150 (25 packs of 6x1) hard capsules and 25 inhalers.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nuremberg
Germany
Novartis Farmacéutica SA
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
You can request more information about this medication by contacting the local representative of the marketing authorisation holder:
België/Belgique/Belgien Novartis Pharma N.V. Tel: +32 2 246 16 11 | Lietuva SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Luxembourg/Luxemburg Novartis Pharma N.V. Tel: +32 2 246 16 11 | |
Ceská republika Novartis s.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 88 04 52 111 |
Eesti SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
Ελλάδα Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12 INNOVIS PHARMA ΑΕΒΕ Τηλ: +30 210 66 64 805-6 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Ferrer Internacional, S.A. Tel: +34 93 600 37 00 | Polska Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Laboratório Medinfar - Produtos Farmacêuticos, S.A. Tel: +351 21 499 7400 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 Italia Alfasigma S.p.A. Tel: +39 06 91 39 4666 Κύπρος Novartis Pharma Services Inc. Τηλ: +357 22 690 690 Latvija SIA Novartis Baltics Tel: +371 67 887 070 | Slovenská republika Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 Suomi/Finland Novartis Finland Oy Puh/Tel: +358 (0)10 6133 200 Sverige Novartis Sverige AB Tel: +46 8 732 32 00 |
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency web site: http://www.ema.europa.eu
Read the Instructions for Usecarefully before using Xoterna Breezhaler.
Insert | Puncture and Release |
| Check that the Capsule is Empty |
Step 1a: Remove the Cap | Step 2a: Puncture the Capsule Once Hold the inhaler in a vertical position. Puncture the capsule by pressing both buttons firmly at the same time. | Step 3a: Exhale Completely Do not blow into the inhaler. | Check that the Capsule is Empty Open the inhaler to check if there is any powder left in the capsule. |
You should hear a sound when the capsule is punctured. Puncture the capsule only once. | If there is powder left in the capsule:
Powder RemainingEmpty | ||
Step 1b: Open the Inhaler | Step 2b: Release the Buttons Completely | Step 3b: Inhale the Medication Deeply Hold the inhaler as shown in the figure. Insert the mouthpiece into your mouth and close your lips firmly around it. Do not press the buttons. | |
Inhale quickly and as deeply as possible. You will hear a whirring sound during inhalation. You may notice the taste of the medication when you inhale. | |||
Step 1c: Remove the Capsule Separate one of the blisters from the blister strip. Open the blister and remove a capsule. Do not press the capsule through the foil. Do not swallow the capsule. | Step 3c: Hold your Breath Hold your breath for 5 seconds | Remove the Empty Capsule Discard the empty capsule in your household trash. Close the inhaler and replace the cap. | |
Step 1d: Insert the Capsule Never place the capsule directly into the mouthpiece. | Important Information
| ||
Step 1e: Close the Inhaler. |
Your Xoterna Breezhaler package contains:
| Frequently Asked Questions Why did the inhaler not make a sound when I inhaled? The capsule may be stuck in the compartment. If this happens, carefully release the capsule by tapping the base of the inhaler. Inhale the medication again, repeating steps 3a to 3c. What should I do if there is powder left in the capsule? You have not received enough of your medication. Close the inhaler and repeat steps 3a to 3c. I coughed after inhaling, is it important? This may occur. If the capsule is empty, it means you have received enough of your medication. I notice small fragments of the capsule on my tongue, is it important? This may occur. It is not harmful. The likelihood of the capsules breaking into pieces increases if the capsule is punctured more than once. | Cleaning the Inhaler Wipe the mouthpiece from the inside and outside with a clean, dry cloth that does not leave lint to remove any powder residue. Keep the inhaler dry. Never wash your inhaler with water. |
Disposal of the Inhaler after Use Each inhaler should be discarded after all the capsules have been used. Ask your pharmacist how to dispose of medications and inhalers that are no longer needed. |
The average price of XOTERNA BREEZHALER 85/43 micrograms powder for inhalation (hard capsule) in October, 2025 is around 70.25 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.